We used a human p53 null cancer cell line to validate transactivation of the cDNA of the p53E224D in a mammalian system and selected the p53E224D mutant for further study because it had been found in human cancers and in Li-Fraumeni syndrome. This evidence concerns the gene TP53 and cancer.